How can identified early presence of atherosclerotic plaque in severe OSAS?

R. Bossi, C. Carnevale, R. Meazza (Milan, Italy)

Source: Annual Congress 2011 - Obstructive sleep apnoea: inflammation and metabolism
Session: Obstructive sleep apnoea: inflammation and metabolism
Session type: Poster Discussion
Number: 3052
Disease area: Sleep and breathing disorders

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Bossi, C. Carnevale, R. Meazza (Milan, Italy). How can identified early presence of atherosclerotic plaque in severe OSAS?. Eur Respir J 2011; 38: Suppl. 55, 3052

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The subclinical atherosclerosis and its association to clinical features of stable COPD
Source: Annual Congress 2011 - COPD management
Year: 2011

A study on the association between the severity of newly diagnosed obstructive sleep apnea and subclinical carotid atherosclerosis in patients without overt cardiovascular disease
Source: International Congress 2016 – Hypoxia, oxidative stress, and biomarkers in obstructive sleep apnoea
Year: 2016

The role of hepcidin in early diagnostic of atherosclerosis in OSA
Source: Virtual Congress 2020 – Consequences for obstructive sleep apnoea and potential modalities for early identification
Year: 2020


Increased arterial remodelling in smokers and mild-moderate COPD patients are indicative of potential early onset of pulmonary hypertension.
Source: Virtual Congress 2021 – Mechanistic pathways in chronic and new lung diseases
Year: 2021



Coronary plaque distribution and endothelial dysfunction in younger obstructive sleep apnea patients
Source: Annual Congress 2011 - Obstructive sleep apnoea: inflammation and metabolism
Year: 2011


Do nocturnal apnoeas contribute to increased cardiovascular risk in end stage renal disease patients?
Source: Annual Congress 2008 - Weight control and comorbidity in obstructive sleep apnoea
Year: 2008

Bacterial burden in the lower airways predicts disease progression in idiopathic pulmonary fibrosis and is independent of radiological disease extent
Source: Eur Respir J, 55 (4) 1901519; 10.1183/13993003.01519-2019
Year: 2020



Is OSAS a systemic disease?
Source: Research Seminar 2007 - Metabolic Aspects of the Obstructive Sleep Apnea Syndrome (OSAS)
Year: 2007


An early prediction of intravascular microthromb formation for patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2009 - Pulmonary circulation I
Year: 2009

The study of the damage degree of myocardial coronary blood flow in patients with chronic obstructive pulmonary disease and severe bronchial asthma
Source: Annual Congress 2008 - Comorbid cardiovascular condition and therapy of asthma
Year: 2008

Differences in vessel endothelium function in severe COPD and severe asthma patients
Source: Eur Respir J 2006; 28: Suppl. 50, 404s
Year: 2006

Angiographically objectified presence of coronary artery disease in patients with exacerbated chronic obstructive pulmonary disease and raised troponin I - The BEETHOVEN trial
Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Year: 2015


Prevalence of cardiovascular risk factors and coronary artery disease in patients with obstructive sleep apnea syndrome (OSAS) requiring CPAP treatment
Source: Eur Respir J 2006; 28: Suppl. 50, 814s
Year: 2006

Relationship between circulating thrombomodulin levels and latent progression of atherosclerosis in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous
Year: 2008


Analysis of atherosclerosis in patients with chronic obstructive pulmonary disease by carotid ultrasonography
Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases
Year: 2011


Leukocytosis as a marker of chronic inflammation and early cardiovascular risk in patients with obstructive sleep apnea syndrome
Source: Eur Respir J 2007; 30: Suppl. 51, 593s
Year: 2007

Increased intima-media thickness in stable COPD – is systemic inflammation the cause?
Source: Annual Congress 2007 - Different aspects of COPD exacerbations
Year: 2007


Is obstructive sleep apnea a risk factor for the progression of thoracic aortic aneurysm? A prospective cohort study.
Source: International Congress 2018 – Sleep-disordered breathing: cardiovascular consequences, epidemiology, phenotypes and comorbidities
Year: 2018



COPD phenotypes not linked to increased risk of coronary heart disease
Source: International Congress 2019 – Comorbidities galore in respiratory patients
Year: 2019




The relationship between the severity of obstructive sleep apnea syndrome and severity of chronic obstructive pulmonary disease (COPD) associated with coronary artery disease (CAD)
Source: International Congress 2016 – Features and impact of comorbidities in COPD
Year: 2016